, Nov. 29, 2023 (GLOBE NEWSWIRE) — .
' .
[...] Read more »
King Faisal Specialist Hospital and Research Center Honors Two Decades of Heartfelt Employee Commitment
RIYADH, Saudi Arabia, Nov. 29, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Center takes great pride in recognizing the exceptional dedication of its diverse workforce, with each member [...] Read more »
Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform
JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, reported [...] Read more »
bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week
- bioLytical, in partnership with NGO Coalition PLUS, has donated over 8,000 rapid tests across 25 countries and partner organizations
- bioLytical is a Canadian company that develops and manufactures all its tests [...] Read more »
International Center for Genetic Disease, Mass General Brigham launches a global Clinical Genomic Medicine and Genetic Counseling training program in United Arab Emirates
Boston, MA, Nov. 21, 2023 (GLOBE NEWSWIRE) — Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one size fits all' approach to one [...] Read more »
International Center for Genetic Disease, Mass General Brigham launches a global Clinical Genomic Medicine and Genetic Counseling training program in United Arab Emirates
Boston, MA, Nov. 20, 2023 (GLOBE NEWSWIRE) — Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one size fits all' approach to one [...] Read more »
Fortrea kündigt KI-gestützte Partnerschaft mit Medidata zur Erhöhung der Diversität in klinischen Studien an
DURHAM, North Carolina, Nov. 20, 2023 (GLOBE NEWSWIRE) — Read more »
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) — Read more »
Fortrea annonce un partenariat avec Medidata basé sur l’IA afin d’accroître la diversité dans les essais cliniques
DURHAM, Caroline du Nord, 20 nov. 2023 (GLOBE NEWSWIRE) — Read more »
Fortrea Anuncia Parceria Baseada em IA com a Medidata para Aumentar a Diversidade dos Ensaios Clínicos
DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) — A Read more »
OPEN Health unites patient engagement experts to transform the patient experience
London, Nov. 20, 2023 (GLOBE NEWSWIRE) — London, UK "" November 20, 2023 "" OPEN Health, a preeminent global provider of Read more »
Know how to manage and prevent diabetes for a better life
BRUSSELS, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) — The International Sweeteners Association (ISA) proudly renews its support to Read more »
Apprendre à traiter et à prévenir le diabète pour mieux vivre
Bruxelles, 14 nov. 2023 (GLOBE NEWSWIRE) — L'Association internationale des dulcorants (ISA) est fire de renouveler son soutien la Read more »
Entera Bio Reports Key Milestone Relating to Oral PTH (1-34) Peptide (EB613) Phase 3 Program: ASBMR-SABRE Has Submitted to FDA the Full Qualification Plan to Approve BMD as a Surrogate Endpoint for Osteoporosis
JERUSALEM, Nov. 09, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, reports [...] Read more »
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
London, Nov. 09, 2023 (GLOBE NEWSWIRE) —
London, UK "" November 9, 2023 "" Read more »